Crossmark

Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial

Crossref DOI link: https://doi.org/10.1007/s13224-024-02061-w

Published Online: 2024-11-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abutaleb, Hisham

Hussien, Ali https://orcid.org/0009-0001-0309-3770
Khalaf, Mohamed

Badary, Dalia M.

Ismail, Alaa M.

Hassanein, Sara

AlGizawy, Samy

Moustafa, S. A. M.

Farghaly, Rabab Mohmed Mumdouh

Abdel-Kawi, A. F.
License Information

Text and Data Mining valid from 2024-11-06

Version of Record valid from 2024-11-06
More Information

Article History

Received: 27 April 2024

Accepted: 3 September 2024

First Online: 6 November 2024

Declarations

:

: The authors declare that they have no conflict of interest.

: Research ethics committee approval was obtained (IRB no. 17200456) from Asyut University on 26 July 2020 Supplementary file 2.

: A written informed consent was obtained from each patient.

Document is current

Any future updates will be listed below